KK
TLSI icon

Kotler Kevin’s TriSalus Life Sciences TLSI Stock Holding History

Kotler Kevin’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.01M Buy
+145,200
New +$813K 0.24% 23

Other funds holding TLSI

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kotler Kevin's TLSI Position: Q4 2025 in Review

Kotler Kevin opened a new position in TriSalus Life Sciences (TLSI) in Q4 2025: 145,200 shares worth $1.01M. The stake represents 0.24% of the portfolio and ranks #23 among its holdings.

67 funds tracked by Wall St. Rank hold TLSI as of Q4 2025.

  • Kotler Kevin held 145,200 shares of TriSalus Life Sciences worth $1.01M as of Q4 2025.
  • TriSalus Life Sciences was a new Kotler Kevin position in Q4 2025.
  • TriSalus Life Sciences made up 0.24% of Kotler Kevin's portfolio in Q4 2025, its #23 holding.
  • 67 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2025.

Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.